163 related articles for article (PubMed ID: 9227455)
1. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice.
Buse MG; Robinson KA; Gettys TW; McMahon EG; Gulve EA
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1080-8. PubMed ID: 9227455
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.
Buse MG; Robinson KA; Marshall BA; Mueckler M
J Biol Chem; 1996 Sep; 271(38):23197-202. PubMed ID: 8798515
[TBL] [Abstract][Full Text] [Related]
3. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver.
Robinson KA; Weinstein ML; Lindenmayer GE; Buse MG
Diabetes; 1995 Dec; 44(12):1438-46. PubMed ID: 7589852
[TBL] [Abstract][Full Text] [Related]
4. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
[TBL] [Abstract][Full Text] [Related]
5. Effects of exercise and feeding on the hexosamine biosynthetic pathway in rat skeletal muscle.
Nelson BA; Robinson KA; Koning JS; Buse MG
Am J Physiol; 1997 May; 272(5 Pt 1):E848-55. PubMed ID: 9176185
[TBL] [Abstract][Full Text] [Related]
6. Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. reversal with GH, but not IGF-I, therapy.
Robinson KA; Willi SM; Bingel S; Buse MG
Am J Physiol; 1999 Mar; 276(3):E435-42. PubMed ID: 10070007
[TBL] [Abstract][Full Text] [Related]
7. Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.
Pouwels MJ; Span PN; Tack CJ; Olthaar AJ; Sweep CG; van Engelen BG; de Jong JG; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2002 Nov; 87(11):5179-84. PubMed ID: 12414889
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
Cooksey RC; Hebert LF; Zhu JH; Wofford P; Garvey WT; McClain DA
Endocrinology; 1999 Mar; 140(3):1151-7. PubMed ID: 10067838
[TBL] [Abstract][Full Text] [Related]
9. Decreased insulin-stimulated GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats.
Kawanaka K; Han DH; Nolte LA; Hansen PA; Nakatani A; Holloszy JO
Am J Physiol; 1999 May; 276(5):E907-12. PubMed ID: 10329985
[TBL] [Abstract][Full Text] [Related]
10. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
11. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment.
Bosch RR; Pouwels MJ; Span PN; Olthaar AJ; Tack CJ; Hermus AR; Sweep CG
Endocrine; 2004 Feb; 23(1):17-24. PubMed ID: 15034192
[TBL] [Abstract][Full Text] [Related]
12. Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.
Chen H; Ing BL; Robinson KA; Feagin AC; Buse MG; Quon MJ
Mol Cell Endocrinol; 1997 Nov; 135(1):67-77. PubMed ID: 9453242
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
McClain DA; Hazel M; Parker G; Cooksey RC
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
[TBL] [Abstract][Full Text] [Related]
14. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker Diabetic Fatty rats.
Bosch RR; Janssen SW; Span PN; Olthaar A; van Emst-de Vries SE; Willems PH; Martens J M G; Hermus AR; Sweep CC
Endocrine; 2003 Apr; 20(3):247-52. PubMed ID: 12721503
[TBL] [Abstract][Full Text] [Related]
15. Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.
Hebert LF; Daniels MC; Zhou J; Crook ED; Turner RL; Simmons ST; Neidigh JL; Zhu JS; Baron AD; McClain DA
J Clin Invest; 1996 Aug; 98(4):930-6. PubMed ID: 8770864
[TBL] [Abstract][Full Text] [Related]
17. Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.
Cuendet GS; Loten EG; Jeanrenaud B; Renold AE
J Clin Invest; 1976 Nov; 58(5):1078-88. PubMed ID: 993331
[TBL] [Abstract][Full Text] [Related]
18. Glucose catabolic gene mRNA levels in skeletal muscle exhibit non-coordinate expression in hyperglycemic mice.
Kato M; Suwa A; Shimokawa T
Horm Metab Res; 2004 Aug; 36(8):513-8. PubMed ID: 15326559
[TBL] [Abstract][Full Text] [Related]
19. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
20. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.
McClain DA; Lubas WA; Cooksey RC; Hazel M; Parker GJ; Love DC; Hanover JA
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10695-9. PubMed ID: 12136128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
